In 2020, the Biophysics & Structural Biology (B2S), Cytometry and Proteomics facilities of the UMS IBSLor and the Clinical Epidemiology Investigation Center (APEMAC - CIC-EC 1433) obtained the StAR-LUE label of the INFRA+ program.

A novel treatment for septic shock has been developed by Prof. Danièle BENSOUSSAN. Accompanied by SATT SAYENS, this development led to the creation of the start-up company StemInov, co-founded by Julie HUTIN, a centralist, with the support of the Lorraine Incubator from the outset.

On the occasion of March 8, 2021, International Women's Rights Day, an interview with Pauline LEFEBVRE, lecturer at the IADI laboratory, has been posted on Factuel.

Subscribe to Distinction